TWM
ABBV icon

Tortuga Wealth Management’s AbbVie ABBV Stock Holding History

Tortuga Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$766K Buy
3,521
+249
+8% +$55.2K 0.72% 34
2025
Q4 		$748K Buy
+3,272
New +$745K 0.79% 29

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tortuga Wealth Management's ABBV Position: Q1 2026 in Review

Tortuga Wealth Management increased its AbbVie (ABBV) stake by 7.6% in Q1 2026, buying an estimated $55.2K and bringing the position to 3,521 shares worth $766K. The position accounts for 0.72% of the portfolio, ranked #34.

Tortuga Wealth Management first reported a position in ABBV in Q4 2025 and has held it in 2 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Tortuga Wealth Management held 3,521 shares of AbbVie worth $766K as of Q1 2026.
  • Tortuga Wealth Management bought 249 AbbVie shares in Q1 2026, an estimated $55.2K.
  • AbbVie made up 0.72% of Tortuga Wealth Management's portfolio in Q1 2026, its #34 holding.
  • Tortuga Wealth Management first reported a position in AbbVie in Q4 2025 and has held it in 2 quarters since.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Tortuga Wealth Management's 13F filing for Q1 2026, filed 17 Jul 2026.